We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
(-18%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$9.86M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$9.7M |
| 3 |
CNR
Core Natural Resources Inc
CNR
|
+$8.26M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$6.63M |
| 5 |
Oracle
ORCL
|
+$6.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$14M |
| 2 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$11.1M |
| 3 |
NVIDIA
NVDA
|
+$9.36M |
| 4 |
Amazon
AMZN
|
+$8.75M |
| 5 |
Netflix
NFLX
|
+$8.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.2% |
| 2 | Healthcare | 10.48% |
| 3 | Consumer Discretionary | 9.93% |
| 4 | Financials | 7.26% |
| 5 | Communication Services | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
OFG Bancorp
OFG
$2.22B
| $229K | 0.02% |
+5,726
| New | +$240K |
|
852
RLI Corp
RLI
$5.87B
| $228K | 0.02% |
+2,842
| New | +$216K |
|
853
Lithia Motors
LAD
$8.42B
| $228K | 0.02% |
+776
| New | +$264K |
|
854
Bruker
BRKR
$8.61B
| $228K | 0.02% |
+5,456
| New | +$284K |
|
855
TKO Group
TKO
$14.1B
| $227K | 0.02% |
1,488
-2,732
| -65% | -$417K |
|
856
PROG Holdings
PRG
$1.65B
| $227K | 0.02% |
+8,540
| New | +$302K |
|
857
Alcoa
AA
$14.1B
| $227K | 0.02% |
7,436
-50,641
| -87% | -$1.77M |
|
858
Trinity Industries
TRN
$2.3B
| $227K | 0.02% |
+8,076
| New | +$271K |
|
|
WOW
859
DELISTED
WideOpenWest
WOW
| $227K | 0.02% |
+45,777
| New | +$211K |
|
|
GES
860
DELISTED
Guess Inc
GES
| $226K | 0.02% |
+20,408
| New | +$246K |
|
|
IAS
861
DELISTED
Integral Ad Science
IAS
| $226K | 0.02% |
28,027
+13,334
| +91% | +$133K |
|
862
Regeneron Pharmaceuticals
REGN
$83.1B
| $226K | 0.02% |
+356
| New | +$245K |
|
863
Colgate-Palmolive
CL
$73.9B
| $226K | 0.02% |
2,409
-11,067
| -82% | -$991K |
|
864
Edison International
EIX
$26.6B
| $225K | 0.02% |
3,814
-15,134
| -80% | -$870K |
|
865
VSE Corp
VSEC
$6.57B
| $225K | 0.02% |
+1,871
| New | +$201K |
|
|
ARIS
866
DELISTED
Aris Water Solutions
ARIS
| $224K | 0.02% |
+7,000
| New | +$199K |
|
867
Enova International
ENVA
$6.4B
| $224K | 0.02% |
2,319
+66
| +3% | +$6.79K |
|
868
PJT Partners
PJT
$4.47B
| $224K | 0.02% |
+1,624
| New | +$255K |
|
869
Clear Channel Outdoor Holdings
CCO
$1.23B
| $224K | 0.02% |
201,614
| – | – |
|
|
YARW
870
Yarrow Bioscience, Inc. Common Stock
YARW
$112M
| $224K | 0.02% |
2,830
+1,642
| +138% | +$202K |
|
|
ARIS
871
Aris Mining
ARIS
$3.51B
| $223K | 0.02% |
48,091
-6,384
| -12% | -$25.4K |
|
872
Inspire Medical Systems
INSP
$1.75B
| $223K | 0.02% |
+1,400
| New | +$253K |
|
873
Delcath Systems
DCTH
$599M
| $223K | 0.02% |
17,516
-19,810
| -53% | -$281K |
|
874
SiriusXM
SIRI
$9.64B
| $223K | 0.02% |
9,887
-12,728
| -56% | -$300K |
|
875
Crown Holdings
CCK
$13.2B
| $223K | 0.02% |
+2,497
| New | +$218K |
|
Similar funds
PFBT
SP
HCS
SPC
GPCM
MCM
CC
MB
Prelude Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.
- Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
- Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
- Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
- Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
- Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
- Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
- Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.
Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.